Monomorphic Post-Transplant Lymphoproliferative Disorder of the Tongue: A Case Report
Author Information
Author(s): Luis F Gonzalez-Cuyar, Fabio Tavora, Allen P Burke, Christopher D Gocke, Ann Zimrin, John J Sauk, Xiafeng Zhao
Primary Institution: University of Maryland School of Medicine
Hypothesis
Can monomorphic post-transplant lymphoproliferative disorder (PTLD) of the tongue be effectively treated by reducing immunosuppression?
Conclusion
The case highlights the potential for complete remission of PTLD in the oral cavity through the reduction of immunosuppressive therapy.
Supporting Evidence
- The patient achieved complete remission after reducing immunosuppressive therapy.
- PTLD is a rare complication following organ transplantation, particularly in the oral cavity.
- Literature review revealed only a few similar cases of PTLD in the oral cavity.
Takeaway
This study shows that a rare type of cancer in the mouth, which can happen after organ transplants, can go away if doctors lower the medicine that weakens the immune system.
Methodology
The study involved morphologic and immunophenotypic analysis of a case of PTLD and a literature review of similar cases.
Limitations
The study is based on a single case report, limiting the generalizability of the findings.
Participant Demographics
A 47-year-old Caucasian male with a history of diabetes and previous organ transplantation.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website